1. Allergan Raises Profit Forecast as Valeant Pursues Bid

    Allergan Raises Profit Forecast as Valeant Pursues Bid

    Profit in the third quarter will be $1.76 to $1.78 per share, above the company’s previous forecast of $1.44 to $1.47, the company said in a statement today. Earnings this year, next year and in 2016 will be higher than analysts are estimating, the Irvine, California-based company said...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned